A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
Clinical trial NCT06699472 · RECRUITING
Trial details
- NCT number
- NCT06699472
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-09-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.